Determining the value of medical technologies to treat ultra-rare disorders: a consensus statement

BACKGROUND: In most jurisdictions, policies have been adopted to encourage the development of treatments for rare or orphan diseases. While successful as assessed against their primary objective, these policies have prompted concerns among payers about the economic burden that might be caused by an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Mark Access Health Policy
Main Authors: Schlander, Michael, Garattini, Silvio, Kolominsky-Rabas, Peter, Nord, Erik, Persson, Ulf, Postma, Maarten, Richardson, Jeff, Simoens, Steven, de Solà-Morales, Oriol, Tolley, Keith, Toumi, Mondher
Formato: Artigo
Idioma:Inglês
Publicado em: Co-Action Publishing 2016
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5087264/
https://ncbi.nlm.nih.gov/pubmed/27857828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jmahp.v4.33039
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados